Literature DB >> 29202959

Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained infertility.

Eleni A Greenwood1, Marcelle I Cedars2, Nanette Santoro3, Esther Eisenberg4, Chia-Ning Kao2, Daniel J Haisenleder5, Michael P Diamond6, Heather G Huddleston2.   

Abstract

OBJECTIVE: To test the hypothesis that women with unexplained infertility demonstrate evidence of diminished ovarian reserve when compared with a population of community controls.
DESIGN: Cross-sectional study.
SETTING: Multicenter university-based clinical practices. PATIENT(S): Study participants included 277 healthy, normo-ovulatory female partners with rigorously defined unexplained infertility randomly selected from a multicenter trial (Assessment of Multiple Intrauterine Gestations from Ovarian Stimulation). Controls included 226 healthy, normo-ovulatory women not seeking treatment for fertility from a community-based cohort (Ovarian Aging study). INTERVENTION(S): Serum antimüllerian hormone (AMH) assay at a central laboratory, FSH, fasting serum metabolic testing, transvaginal ultrasonography for antral follicle counts (AFCs), anthropometric measurements. MAIN OUTCOME MEASURE(S): Average AMH, AFC, and AMH/AFC were compared between infertile and control women by age. Analyses of covariance compared these outcomes while controlling for confounders, including age, race, body mass index, smoking history, and study site. RESULT(S): In our models, AMH, AFC, and AMH/AFC ovarian reserve indices did not differ between infertile women and community-based controls, after controlling for age, race, body mass index, smoking history, and study site. CONCLUSION(S): Currently utilized predictors of ovarian reserve do not discriminate women with rigorously defined unexplained infertility from healthy community-based women of similar demographic characteristics. Contrary to our hypothesis, among women with FSH in the normal range (≤12 IU/L), women with unexplained infertility did not show evidence of decreased ovarian reserve as measured by AMH and AFC. Ovarian reserve markers in isolation may not serve as predictors of future fertility.
Copyright © 2017 American Society for Reproductive Medicine. All rights reserved.

Entities:  

Keywords:  AFC; AMH; ovarian reserve; unexplained infertility

Mesh:

Substances:

Year:  2017        PMID: 29202959     DOI: 10.1016/j.fertnstert.2017.09.015

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  6 in total

1.  Chemotherapy-related damage to ovarian reserve in childhood cancer survivors: interpreting the evidence.

Authors:  Edgardo Somigliana; Monica Terenziani; Francesca Filippi; Alice Bergamini; Fabio Martinelli; Giorgia Mangili; Fedro Peccatori; Paolo Vercellini
Journal:  J Assist Reprod Genet       Date:  2018-10-25       Impact factor: 3.412

2.  Do young women with unexplained infertility show manifestations of decreased ovarian reserve?

Authors:  Noa Abrahami; Ido Izhaki; Johnny S Younis
Journal:  J Assist Reprod Genet       Date:  2019-05-21       Impact factor: 3.412

3.  Do BRCA1 and BRCA2 gene mutation carriers have a reduced ovarian reserve? Protocol for a prospective observational study.

Authors:  Amy Louise Winship; Chris Willson; Karl R Hansen; Karla J Hutt; Martha Hickey
Journal:  BMJ Open       Date:  2019-11-25       Impact factor: 2.692

4.  The status and comparison of ovarian reserve between fertile and infertile healthy Chinese women of reproductive age.

Authors:  Shan-Jie Zhou; Tie-Cheng Sun; Ling-Li Song; Ming Yang; Xin-Ping Sun; Li Tian
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

5.  Increased Body Mass Index Is Associated With A Nondilutional Reduction in Antimüllerian Hormone.

Authors:  Eleni Greenwood Jaswa; Julie S Rios; Marcelle I Cedars; Nanette F Santoro; Mary Ellen G Pavone; Richard S Legro; Heather G Huddleston
Journal:  J Clin Endocrinol Metab       Date:  2020-10-01       Impact factor: 5.958

Review 6.  Serum Anti-Müllerian Hormone Levels and Risk of Premature Ovarian Insufficiency in Female Childhood Cancer Survivors: Systematic Review and Network Meta-Analysis.

Authors:  Marco Torella; Gaetano Riemma; Pasquale De Franciscis; Marco La Verde; Nicola Colacurci
Journal:  Cancers (Basel)       Date:  2021-12-16       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.